Mark Fendrick, MD, Discusses Value-Based Insurance Design
Dr. Mark Fendrick, MD, Professor of Medicine and Health Management and Policy, Schools of Medicine and Public Health, University of Michigan, Co-Editor-in-Chief, The American Journal of Managed Care, says that there are levers organizations and stakeholders can pull to achieve the goal of improving quality and value in cancer care. Dr. Fendrick discusses the importance of combining the supply side, or how you pay doctors, and the demand side of value, or consumer engagement. Dr. Fendrick also says that the goal of improved health and cost containment can be achieved when the two sides are combined.
This video was taken on November 16 at AJMC's Translating Evidence-Based Research Into Value-Based Decisions in Oncology.
The FDA today granted accelerated approval to olaparib, a poly ADP-ribose polymerase (PARP) inhibitor, for treatment of advanced ovarian cancer in women with defected BRCA genes, along with a companion diagnostic test that marked the agency’s first approval of a laboratory developed test (LDT) under a premarket approval application.
The annual estimated cost of mental healthcare is $80-$100 billion in direct costs, but Paul Gionfreddo and Stuart Lustig, MD, both don’t believe that any more cost savings can be realized by squeezing the back end of the system.
Fresh off re-election, Governor Robert Bentley moved this week to name 6 groups to coordinate managed care in Medicaid, as part of a cost-saving strategy he launched in 2012. But the bigger news has been his reversal on expanding the program; as in other Southern states, hospitals have been pressing for the change to solve fiscal problems.
In this segment, the panelists analyze current programs that aim to educate and guide key stakeholders through the facets of cancer care and conclude that collaboration can help control costs and drive quality.
All medical illnesses have issues with nonadherence and part of the reason is because the American health system doesn’t provide the right education, support, and close follow-up needed to get the right medicine to the right person, Wayne Katon, MD, said.